nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—ALB—acquired immunodeficiency syndrome	0.198	1	CbGaD
Acetylsalicylic acid—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0442	0.0828	CbGbCtD
Acetylsalicylic acid—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0414	0.0776	CbGbCtD
Acetylsalicylic acid—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0335	0.0628	CbGbCtD
Acetylsalicylic acid—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0176	0.033	CbGbCtD
Acetylsalicylic acid—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0159	0.0299	CbGbCtD
Acetylsalicylic acid—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0159	0.0299	CbGbCtD
Acetylsalicylic acid—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0157	0.0295	CbGbCtD
Acetylsalicylic acid—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0156	0.0293	CbGbCtD
Acetylsalicylic acid—ALB—Zidovudine—acquired immunodeficiency syndrome	0.015	0.0281	CbGbCtD
Acetylsalicylic acid—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0148	0.0277	CbGbCtD
Acetylsalicylic acid—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0136	0.0255	CbGbCtD
Acetylsalicylic acid—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0134	0.0251	CbGbCtD
Acetylsalicylic acid—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0134	0.0251	CbGbCtD
Acetylsalicylic acid—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0131	0.0245	CbGbCtD
Acetylsalicylic acid—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0123	0.023	CbGbCtD
Acetylsalicylic acid—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0123	0.023	CbGbCtD
Acetylsalicylic acid—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0121	0.0226	CbGbCtD
Acetylsalicylic acid—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0121	0.0226	CbGbCtD
Acetylsalicylic acid—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0119	0.0224	CbGbCtD
Acetylsalicylic acid—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0116	0.0217	CbGbCtD
Acetylsalicylic acid—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0115	0.0216	CbGbCtD
Acetylsalicylic acid—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0112	0.021	CbGbCtD
Acetylsalicylic acid—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0111	0.0208	CbGbCtD
Acetylsalicylic acid—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0111	0.0208	CbGbCtD
Acetylsalicylic acid—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0108	0.0202	CbGbCtD
Acetylsalicylic acid—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.019	CbGbCtD
Acetylsalicylic acid—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0101	0.019	CbGbCtD
Acetylsalicylic acid—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00972	0.0182	CbGbCtD
Acetylsalicylic acid—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0096	0.018	CbGbCtD
Acetylsalicylic acid—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00932	0.0175	CbGbCtD
Acetylsalicylic acid—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00931	0.0175	CbGbCtD
Acetylsalicylic acid—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00904	0.0169	CbGbCtD
Acetylsalicylic acid—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00843	0.0158	CbGbCtD
Acetylsalicylic acid—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00843	0.0158	CbGbCtD
Acetylsalicylic acid—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00818	0.0153	CbGbCtD
Acetylsalicylic acid—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00818	0.0153	CbGbCtD
Acetylsalicylic acid—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00808	0.0151	CbGbCtD
Acetylsalicylic acid—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00784	0.0147	CbGbCtD
Acetylsalicylic acid—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00606	0.0114	CbGbCtD
Acetylsalicylic acid—NFKBIA—nerve—acquired immunodeficiency syndrome	0.00335	0.0442	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—acquired immunodeficiency syndrome	0.00329	0.0433	CbGeAlD
Acetylsalicylic acid—TP53—endothelium—acquired immunodeficiency syndrome	0.0029	0.0382	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—acquired immunodeficiency syndrome	0.00286	0.0376	CbGeAlD
Acetylsalicylic acid—HSPA5—blood plasma—acquired immunodeficiency syndrome	0.00248	0.0327	CbGeAlD
Acetylsalicylic acid—NFKBIA—retina—acquired immunodeficiency syndrome	0.00139	0.0183	CbGeAlD
Acetylsalicylic acid—HSPA5—retina—acquired immunodeficiency syndrome	0.00136	0.0179	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—acquired immunodeficiency syndrome	0.00124	0.0163	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—acquired immunodeficiency syndrome	0.00122	0.0161	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—acquired immunodeficiency syndrome	0.00119	0.0157	CbGeAlD
Acetylsalicylic acid—RPS6KA3—retina—acquired immunodeficiency syndrome	0.00116	0.0153	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—acquired immunodeficiency syndrome	0.001	0.0132	CbGeAlD
Acetylsalicylic acid—TP53—digestive system—acquired immunodeficiency syndrome	0.000992	0.0131	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—acquired immunodeficiency syndrome	0.000988	0.013	CbGeAlD
Acetylsalicylic acid—NFKBIA—digestive system—acquired immunodeficiency syndrome	0.000975	0.0128	CbGeAlD
Acetylsalicylic acid—HSPA5—lymphoid tissue—acquired immunodeficiency syndrome	0.000967	0.0127	CbGeAlD
Acetylsalicylic acid—HSPA5—digestive system—acquired immunodeficiency syndrome	0.000955	0.0126	CbGeAlD
Acetylsalicylic acid—TP53—blood—acquired immunodeficiency syndrome	0.000945	0.0124	CbGeAlD
Acetylsalicylic acid—NFKBIA—blood—acquired immunodeficiency syndrome	0.000929	0.0122	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—acquired immunodeficiency syndrome	0.000914	0.012	CbGeAlD
Acetylsalicylic acid—HSPA5—blood—acquired immunodeficiency syndrome	0.00091	0.012	CbGeAlD
Acetylsalicylic acid—TP53—spinal cord—acquired immunodeficiency syndrome	0.00091	0.012	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—acquired immunodeficiency syndrome	0.000899	0.0118	CbGeAlD
Acetylsalicylic acid—NFKBIA—spinal cord—acquired immunodeficiency syndrome	0.000895	0.0118	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—acquired immunodeficiency syndrome	0.000881	0.0116	CbGeAlD
Acetylsalicylic acid—HSPA5—spinal cord—acquired immunodeficiency syndrome	0.000877	0.0115	CbGeAlD
Acetylsalicylic acid—TP53—vagina—acquired immunodeficiency syndrome	0.000876	0.0115	CbGeAlD
Acetylsalicylic acid—NFKBIA—vagina—acquired immunodeficiency syndrome	0.000861	0.0113	CbGeAlD
Acetylsalicylic acid—HSPA5—vagina—acquired immunodeficiency syndrome	0.000844	0.0111	CbGeAlD
Acetylsalicylic acid—TP53—lung—acquired immunodeficiency syndrome	0.000828	0.0109	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—acquired immunodeficiency syndrome	0.000824	0.0108	CbGeAlD
Acetylsalicylic acid—NFKBIA—lung—acquired immunodeficiency syndrome	0.000815	0.0107	CbGeAlD
Acetylsalicylic acid—HSPA5—lung—acquired immunodeficiency syndrome	0.000798	0.0105	CbGeAlD
Acetylsalicylic acid—RPS6KA3—blood—acquired immunodeficiency syndrome	0.000775	0.0102	CbGeAlD
Acetylsalicylic acid—TP53—nervous system—acquired immunodeficiency syndrome	0.000767	0.0101	CbGeAlD
Acetylsalicylic acid—NFKBIA—nervous system—acquired immunodeficiency syndrome	0.000754	0.00993	CbGeAlD
Acetylsalicylic acid—IKBKB—skin of body—acquired immunodeficiency syndrome	0.000751	0.00989	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—acquired immunodeficiency syndrome	0.00075	0.00988	CbGeAlD
Acetylsalicylic acid—RPS6KA3—spinal cord—acquired immunodeficiency syndrome	0.000747	0.00984	CbGeAlD
Acetylsalicylic acid—HSPA5—nervous system—acquired immunodeficiency syndrome	0.000739	0.00973	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—acquired immunodeficiency syndrome	0.000738	0.00972	CbGeAlD
Acetylsalicylic acid—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000734	0.00967	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—acquired immunodeficiency syndrome	0.000726	0.00956	CbGeAlD
Acetylsalicylic acid—RPS6KA3—vagina—acquired immunodeficiency syndrome	0.000719	0.00946	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—acquired immunodeficiency syndrome	0.000711	0.00937	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lung—acquired immunodeficiency syndrome	0.00068	0.00895	CbGeAlD
Acetylsalicylic acid—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000641	0.00844	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nervous system—acquired immunodeficiency syndrome	0.000629	0.00829	CbGeAlD
Acetylsalicylic acid—IKBKB—lymphoid tissue—acquired immunodeficiency syndrome	0.000608	0.00801	CbGeAlD
Acetylsalicylic acid—RPS6KA3—central nervous system—acquired immunodeficiency syndrome	0.000606	0.00798	CbGeAlD
Acetylsalicylic acid—IKBKB—digestive system—acquired immunodeficiency syndrome	0.000601	0.00791	CbGeAlD
Acetylsalicylic acid—TP53—brain—acquired immunodeficiency syndrome	0.000586	0.00772	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000585	0.00771	CbGeAlD
Acetylsalicylic acid—EDNRA—vagina—acquired immunodeficiency syndrome	0.000584	0.00769	CbGeAlD
Acetylsalicylic acid—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000583	0.00767	CbGeAlD
Acetylsalicylic acid—NFKBIA—brain—acquired immunodeficiency syndrome	0.000577	0.00759	CbGeAlD
Acetylsalicylic acid—IKBKB—blood—acquired immunodeficiency syndrome	0.000572	0.00754	CbGeAlD
Acetylsalicylic acid—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000569	0.0075	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—acquired immunodeficiency syndrome	0.000566	0.00746	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—acquired immunodeficiency syndrome	0.000565	0.00744	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—acquired immunodeficiency syndrome	0.000559	0.00737	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—acquired immunodeficiency syndrome	0.000557	0.00734	CbGeAlD
Acetylsalicylic acid—EDNRA—lung—acquired immunodeficiency syndrome	0.000553	0.00728	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—acquired immunodeficiency syndrome	0.000546	0.00719	CbGeAlD
Acetylsalicylic acid—IKBKB—vagina—acquired immunodeficiency syndrome	0.000531	0.00699	CbGeAlD
Acetylsalicylic acid—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00052	0.00684	CbGeAlD
Acetylsalicylic acid—IKBKB—lung—acquired immunodeficiency syndrome	0.000502	0.00661	CbGeAlD
Acetylsalicylic acid—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000497	0.00654	CbGeAlD
Acetylsalicylic acid—RPS6KA3—brain—acquired immunodeficiency syndrome	0.000481	0.00633	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—acquired immunodeficiency syndrome	0.000465	0.00612	CbGeAlD
Acetylsalicylic acid—IKBKB—nervous system—acquired immunodeficiency syndrome	0.000465	0.00612	CbGeAlD
Acetylsalicylic acid—IKBKB—central nervous system—acquired immunodeficiency syndrome	0.000447	0.00589	CbGeAlD
Acetylsalicylic acid—EDNRA—brain—acquired immunodeficiency syndrome	0.000391	0.00515	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—acquired immunodeficiency syndrome	0.000378	0.00498	CbGeAlD
Acetylsalicylic acid—IKBKB—brain—acquired immunodeficiency syndrome	0.000355	0.00468	CbGeAlD
Acetylsalicylic acid—SLC22A7—brain—acquired immunodeficiency syndrome	0.000344	0.00454	CbGeAlD
Acetylsalicylic acid—IKBKB—lymph node—acquired immunodeficiency syndrome	0.000343	0.00452	CbGeAlD
Acetylsalicylic acid—SLC22A6—brain—acquired immunodeficiency syndrome	0.000333	0.00438	CbGeAlD
Acetylsalicylic acid—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000307	0.00405	CbGeAlD
Acetylsalicylic acid—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000282	0.00372	CbGeAlD
Acetylsalicylic acid—CYP2C19—blood—acquired immunodeficiency syndrome	0.000269	0.00354	CbGeAlD
Acetylsalicylic acid—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.00196	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00195	CcSEcCtD
Acetylsalicylic acid—PTGS1—skin of body—acquired immunodeficiency syndrome	0.00025	0.00329	CbGeAlD
Acetylsalicylic acid—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000249	0.00328	CbGeAlD
Acetylsalicylic acid—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.000248	0.00192	CcSEcCtD
Acetylsalicylic acid—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.00191	CcSEcCtD
Acetylsalicylic acid—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.00189	CcSEcCtD
Acetylsalicylic acid—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.00189	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00189	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00188	CcSEcCtD
Acetylsalicylic acid—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000242	0.00188	CcSEcCtD
Acetylsalicylic acid—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000241	0.00187	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.00186	CcSEcCtD
Acetylsalicylic acid—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.00186	CcSEcCtD
Acetylsalicylic acid—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000239	0.00186	CcSEcCtD
Acetylsalicylic acid—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000239	0.00314	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00183	CcSEcCtD
Acetylsalicylic acid—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000236	0.00183	CcSEcCtD
Acetylsalicylic acid—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00183	CcSEcCtD
Acetylsalicylic acid—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00183	CcSEcCtD
Acetylsalicylic acid—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000235	0.00182	CcSEcCtD
Acetylsalicylic acid—Syncope—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00182	CcSEcCtD
Acetylsalicylic acid—CYP2C8—blood—acquired immunodeficiency syndrome	0.000235	0.00309	CbGeAlD
Acetylsalicylic acid—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.00182	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000234	0.00181	CcSEcCtD
Acetylsalicylic acid—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00181	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000233	0.00181	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000232	0.0018	CcSEcCtD
Acetylsalicylic acid—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.0018	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00179	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00178	CcSEcCtD
Acetylsalicylic acid—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.00177	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000229	0.00177	CcSEcCtD
Acetylsalicylic acid—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.00176	CcSEcCtD
Acetylsalicylic acid—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.00175	CcSEcCtD
Acetylsalicylic acid—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.00175	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.00175	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.00175	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.00175	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000224	0.00174	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00173	CcSEcCtD
Acetylsalicylic acid—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00173	CcSEcCtD
Acetylsalicylic acid—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00172	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.00172	CcSEcCtD
Acetylsalicylic acid—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00172	CcSEcCtD
Acetylsalicylic acid—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000219	0.00288	CbGeAlD
Acetylsalicylic acid—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.0017	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.0017	CcSEcCtD
Acetylsalicylic acid—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000218	0.00287	CbGeAlD
Acetylsalicylic acid—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.00169	CcSEcCtD
Acetylsalicylic acid—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.00169	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.00169	CcSEcCtD
Acetylsalicylic acid—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.00168	CcSEcCtD
Acetylsalicylic acid—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000216	0.00167	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000215	0.00167	CcSEcCtD
Acetylsalicylic acid—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.00166	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00166	CcSEcCtD
Acetylsalicylic acid—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.00166	CcSEcCtD
Acetylsalicylic acid—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00165	CcSEcCtD
Acetylsalicylic acid—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000212	0.00165	CcSEcCtD
Acetylsalicylic acid—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00165	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00164	CcSEcCtD
Acetylsalicylic acid—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000211	0.00163	CcSEcCtD
Acetylsalicylic acid—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00163	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00163	CcSEcCtD
Acetylsalicylic acid—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000211	0.00163	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00021	0.00163	CcSEcCtD
Acetylsalicylic acid—Shock—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00163	CcSEcCtD
Acetylsalicylic acid—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00021	0.00163	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000209	0.00162	CcSEcCtD
Acetylsalicylic acid—CYP2C9—blood—acquired immunodeficiency syndrome	0.000209	0.00275	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000208	0.00162	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00161	CcSEcCtD
Acetylsalicylic acid—ALB—brain—acquired immunodeficiency syndrome	0.000207	0.00273	CbGeAlD
Acetylsalicylic acid—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000207	0.00161	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000207	0.0016	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00159	CcSEcCtD
Acetylsalicylic acid—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.00159	CcSEcCtD
Acetylsalicylic acid—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00158	CcSEcCtD
Acetylsalicylic acid—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00158	CcSEcCtD
Acetylsalicylic acid—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.00157	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.00157	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000202	0.00157	CcSEcCtD
Acetylsalicylic acid—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00156	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00156	CcSEcCtD
Acetylsalicylic acid—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.00156	CcSEcCtD
Acetylsalicylic acid—ALB—lymph node—acquired immunodeficiency syndrome	0.0002	0.00264	CbGeAlD
Acetylsalicylic acid—PTGS1—digestive system—acquired immunodeficiency syndrome	0.0002	0.00263	CbGeAlD
Acetylsalicylic acid—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00154	CcSEcCtD
Acetylsalicylic acid—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000198	0.00154	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.00153	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00153	CcSEcCtD
Acetylsalicylic acid—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00153	CcSEcCtD
Acetylsalicylic acid—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00152	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00152	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000195	0.00152	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00151	CcSEcCtD
Acetylsalicylic acid—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.00151	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000195	0.00151	CcSEcCtD
Acetylsalicylic acid—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.00151	CcSEcCtD
Acetylsalicylic acid—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.0015	CcSEcCtD
Acetylsalicylic acid—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000194	0.0015	CcSEcCtD
Acetylsalicylic acid—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.0015	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000193	0.00255	CbGeAlD
Acetylsalicylic acid—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00149	CcSEcCtD
Acetylsalicylic acid—Rash—Didanosine—acquired immunodeficiency syndrome	0.000192	0.00149	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000192	0.00149	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000192	0.00149	CcSEcCtD
Acetylsalicylic acid—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000191	0.00252	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000191	0.00148	CcSEcCtD
Acetylsalicylic acid—PTGS1—blood—acquired immunodeficiency syndrome	0.00019	0.00251	CbGeAlD
Acetylsalicylic acid—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.00147	CcSEcCtD
Acetylsalicylic acid—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00147	CcSEcCtD
Acetylsalicylic acid—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.00147	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.00147	CcSEcCtD
Acetylsalicylic acid—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00147	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.00147	CcSEcCtD
Acetylsalicylic acid—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.00147	CcSEcCtD
Acetylsalicylic acid—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00147	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00146	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.00146	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000188	0.00146	CcSEcCtD
Acetylsalicylic acid—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.00146	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000187	0.00145	CcSEcCtD
Acetylsalicylic acid—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000187	0.00145	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.00145	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00145	CcSEcCtD
Acetylsalicylic acid—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00145	CcSEcCtD
Acetylsalicylic acid—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.00144	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00144	CcSEcCtD
Acetylsalicylic acid—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000184	0.00143	CcSEcCtD
Acetylsalicylic acid—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00142	CcSEcCtD
Acetylsalicylic acid—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000183	0.00242	CbGeAlD
Acetylsalicylic acid—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00142	CcSEcCtD
Acetylsalicylic acid—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.00142	CcSEcCtD
Acetylsalicylic acid—PTGS2—blood—acquired immunodeficiency syndrome	0.000182	0.0024	CbGeAlD
Acetylsalicylic acid—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.00141	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000182	0.00141	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000181	0.0014	CcSEcCtD
Acetylsalicylic acid—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000181	0.0014	CcSEcCtD
Acetylsalicylic acid—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.0014	CcSEcCtD
Acetylsalicylic acid—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.0014	CcSEcCtD
Acetylsalicylic acid—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.0014	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.0014	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.0014	CcSEcCtD
Acetylsalicylic acid—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00139	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00139	CcSEcCtD
Acetylsalicylic acid—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00139	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000178	0.00138	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00138	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.00137	CcSEcCtD
Acetylsalicylic acid—PTGS1—vagina—acquired immunodeficiency syndrome	0.000176	0.00232	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000176	0.00137	CcSEcCtD
Acetylsalicylic acid—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000176	0.00232	CbGeAlD
Acetylsalicylic acid—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.00136	CcSEcCtD
Acetylsalicylic acid—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000175	0.00136	CcSEcCtD
Acetylsalicylic acid—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000175	0.00231	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00136	CcSEcCtD
Acetylsalicylic acid—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000175	0.00136	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00135	CcSEcCtD
Acetylsalicylic acid—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.00135	CcSEcCtD
Acetylsalicylic acid—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000174	0.00135	CcSEcCtD
Acetylsalicylic acid—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.00135	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00134	CcSEcCtD
Acetylsalicylic acid—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000173	0.00134	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000173	0.00134	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00134	CcSEcCtD
Acetylsalicylic acid—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000172	0.00134	CcSEcCtD
Acetylsalicylic acid—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00133	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.00133	CcSEcCtD
Acetylsalicylic acid—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.00133	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.00132	CcSEcCtD
Acetylsalicylic acid—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00132	CcSEcCtD
Acetylsalicylic acid—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00131	CcSEcCtD
Acetylsalicylic acid—PTGS2—vagina—acquired immunodeficiency syndrome	0.000169	0.00222	CbGeAlD
Acetylsalicylic acid—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000169	0.00131	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00131	CcSEcCtD
Acetylsalicylic acid—ABCB1—retina—acquired immunodeficiency syndrome	0.000168	0.00222	CbGeAlD
Acetylsalicylic acid—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000168	0.0013	CcSEcCtD
Acetylsalicylic acid—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.0013	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.0013	CcSEcCtD
Acetylsalicylic acid—PTGS1—lung—acquired immunodeficiency syndrome	0.000167	0.0022	CbGeAlD
Acetylsalicylic acid—Rash—Stavudine—acquired immunodeficiency syndrome	0.000167	0.00129	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000167	0.00129	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00129	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.00129	CcSEcCtD
Acetylsalicylic acid—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000166	0.00128	CcSEcCtD
Acetylsalicylic acid—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.00128	CcSEcCtD
Acetylsalicylic acid—Rash—Abacavir—acquired immunodeficiency syndrome	0.000164	0.00127	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000164	0.00127	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00127	CcSEcCtD
Acetylsalicylic acid—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.00126	CcSEcCtD
Acetylsalicylic acid—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.00126	CcSEcCtD
Acetylsalicylic acid—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.00125	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.00125	CcSEcCtD
Acetylsalicylic acid—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.00124	CcSEcCtD
Acetylsalicylic acid—PTGS2—lung—acquired immunodeficiency syndrome	0.00016	0.0021	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00124	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00124	CcSEcCtD
Acetylsalicylic acid—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00123	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.00123	CcSEcCtD
Acetylsalicylic acid—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.00122	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000157	0.00122	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.00122	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000157	0.00122	CcSEcCtD
Acetylsalicylic acid—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000157	0.00122	CcSEcCtD
Acetylsalicylic acid—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000155	0.0012	CcSEcCtD
Acetylsalicylic acid—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000155	0.00204	CbGeAlD
Acetylsalicylic acid—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.00119	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00119	CcSEcCtD
Acetylsalicylic acid—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00119	CcSEcCtD
Acetylsalicylic acid—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.00118	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00117	CcSEcCtD
Acetylsalicylic acid—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000151	0.00117	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.00115	CcSEcCtD
Acetylsalicylic acid—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000149	0.00196	CbGeAlD
Acetylsalicylic acid—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000148	0.00195	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.00114	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00113	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000146	0.00113	CcSEcCtD
Acetylsalicylic acid—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.00113	CcSEcCtD
Acetylsalicylic acid—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00113	CcSEcCtD
Acetylsalicylic acid—CYP2C8—brain—acquired immunodeficiency syndrome	0.000146	0.00192	CbGeAlD
Acetylsalicylic acid—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.00112	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.00112	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00112	CcSEcCtD
Acetylsalicylic acid—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00111	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.0011	CcSEcCtD
Acetylsalicylic acid—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000142	0.00187	CbGeAlD
Acetylsalicylic acid—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.0011	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.0011	CcSEcCtD
Acetylsalicylic acid—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000141	0.0011	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.00107	CcSEcCtD
Acetylsalicylic acid—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.00106	CcSEcCtD
Acetylsalicylic acid—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00106	CcSEcCtD
Acetylsalicylic acid—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.00106	CcSEcCtD
Acetylsalicylic acid—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000136	0.00105	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.00105	CcSEcCtD
Acetylsalicylic acid—Rash—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00105	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00104	CcSEcCtD
Acetylsalicylic acid—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.00104	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.00103	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00102	CcSEcCtD
Acetylsalicylic acid—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00101	CcSEcCtD
Acetylsalicylic acid—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000996	CcSEcCtD
Acetylsalicylic acid—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000991	CcSEcCtD
Acetylsalicylic acid—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000988	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000987	CcSEcCtD
Acetylsalicylic acid—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000985	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000983	CcSEcCtD
Acetylsalicylic acid—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000981	CcSEcCtD
Acetylsalicylic acid—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000953	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000948	CcSEcCtD
Acetylsalicylic acid—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000945	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000944	CcSEcCtD
Acetylsalicylic acid—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000944	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000938	CcSEcCtD
Acetylsalicylic acid—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.00093	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.00012	0.00158	CbGeAlD
Acetylsalicylic acid—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000917	CcSEcCtD
Acetylsalicylic acid—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000118	0.00156	CbGeAlD
Acetylsalicylic acid—PTGS1—brain—acquired immunodeficiency syndrome	0.000118	0.00156	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000913	CcSEcCtD
Acetylsalicylic acid—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.0009	CcSEcCtD
Acetylsalicylic acid—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.00089	CcSEcCtD
Acetylsalicylic acid—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000114	0.0015	CbGeAlD
Acetylsalicylic acid—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000882	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000881	CcSEcCtD
Acetylsalicylic acid—PTGS2—brain—acquired immunodeficiency syndrome	0.000113	0.00149	CbGeAlD
Acetylsalicylic acid—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000874	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000873	CcSEcCtD
Acetylsalicylic acid—ABCB1—blood—acquired immunodeficiency syndrome	0.000113	0.00148	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000871	CcSEcCtD
Acetylsalicylic acid—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000848	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000109	0.00144	CbGeAlD
Acetylsalicylic acid—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000109	0.00143	CbGeAlD
Acetylsalicylic acid—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000842	CcSEcCtD
Acetylsalicylic acid—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000841	CcSEcCtD
Acetylsalicylic acid—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000108	0.00143	CbGeAlD
Acetylsalicylic acid—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00084	CcSEcCtD
Acetylsalicylic acid—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000823	CcSEcCtD
Acetylsalicylic acid—ABCB1—vagina—acquired immunodeficiency syndrome	0.000104	0.00137	CbGeAlD
Acetylsalicylic acid—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000809	CcSEcCtD
Acetylsalicylic acid—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000802	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000802	CcSEcCtD
Acetylsalicylic acid—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000792	CcSEcCtD
Acetylsalicylic acid—ABCB1—lung—acquired immunodeficiency syndrome	9.87e-05	0.0013	CbGeAlD
Acetylsalicylic acid—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.75e-05	0.000756	CcSEcCtD
Acetylsalicylic acid—ABCB1—nervous system—acquired immunodeficiency syndrome	9.14e-05	0.0012	CbGeAlD
Acetylsalicylic acid—ABCB1—central nervous system—acquired immunodeficiency syndrome	8.8e-05	0.00116	CbGeAlD
Acetylsalicylic acid—ABCB1—brain—acquired immunodeficiency syndrome	6.98e-05	0.00092	CbGeAlD
Acetylsalicylic acid—ABCB1—lymph node—acquired immunodeficiency syndrome	6.75e-05	0.000889	CbGeAlD
Acetylsalicylic acid—IKBKB—Innate Immune System—MBL2—acquired immunodeficiency syndrome	5.48e-05	0.000862	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TNF—acquired immunodeficiency syndrome	5.45e-05	0.000856	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	5.45e-05	0.000856	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	5.45e-05	0.000856	CbGpPWpGaD
Acetylsalicylic acid—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.41e-05	0.000851	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	5.4e-05	0.000849	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	5.4e-05	0.000848	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	5.39e-05	0.000847	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	5.31e-05	0.000834	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	5.3e-05	0.000832	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.27e-05	0.000828	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.27e-05	0.000828	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	5.2e-05	0.000817	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.18e-05	0.000814	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.18e-05	0.000814	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.18e-05	0.000814	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.18e-05	0.000814	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular Senescence—IL6—acquired immunodeficiency syndrome	5.18e-05	0.000813	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.17e-05	0.000813	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.14e-05	0.000808	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IFNA1—acquired immunodeficiency syndrome	5.07e-05	0.000797	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	5.07e-05	0.000796	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CCR2—acquired immunodeficiency syndrome	5.04e-05	0.000791	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.03e-05	0.00079	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD79A—acquired immunodeficiency syndrome	4.92e-05	0.000774	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—ALB—acquired immunodeficiency syndrome	4.88e-05	0.000766	CbGpPWpGaD
Acetylsalicylic acid—TP53—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	4.86e-05	0.000764	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	4.81e-05	0.000756	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	4.79e-05	0.000753	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4.78e-05	0.000752	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—IL6—acquired immunodeficiency syndrome	4.68e-05	0.000735	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	4.66e-05	0.000733	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.62e-05	0.000726	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.55e-05	0.000715	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IFNA1—acquired immunodeficiency syndrome	4.53e-05	0.000712	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD79A—acquired immunodeficiency syndrome	4.4e-05	0.000692	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	4.35e-05	0.000684	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.34e-05	0.000682	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	4.32e-05	0.000679	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	4.31e-05	0.000678	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	4.31e-05	0.000678	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CCR2—acquired immunodeficiency syndrome	4.3e-05	0.000676	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	4.29e-05	0.000674	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	4.29e-05	0.000674	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.28e-05	0.000672	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.28e-05	0.000672	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.28e-05	0.000672	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	4.24e-05	0.000666	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.21e-05	0.000662	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	4.2e-05	0.000659	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	4.19e-05	0.000658	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CCR5—acquired immunodeficiency syndrome	4.19e-05	0.000658	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.17e-05	0.000655	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.17e-05	0.000655	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.16e-05	0.000654	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IFNG—acquired immunodeficiency syndrome	4.11e-05	0.000646	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.09e-05	0.000643	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.09e-05	0.000642	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	4.09e-05	0.000642	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.03e-05	0.000633	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	4.02e-05	0.000631	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD40LG—acquired immunodeficiency syndrome	4.01e-05	0.000631	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.98e-05	0.000626	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD8A—acquired immunodeficiency syndrome	3.97e-05	0.000624	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CD4—acquired immunodeficiency syndrome	3.97e-05	0.000624	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CSF2—acquired immunodeficiency syndrome	3.97e-05	0.000624	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—IL2—acquired immunodeficiency syndrome	3.95e-05	0.000621	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.94e-05	0.000619	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.94e-05	0.000619	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.91e-05	0.000615	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.91e-05	0.000615	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	3.91e-05	0.000615	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ACTG1—acquired immunodeficiency syndrome	3.89e-05	0.000611	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.88e-05	0.00061	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.88e-05	0.00061	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	3.87e-05	0.000608	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	3.85e-05	0.000606	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-B—acquired immunodeficiency syndrome	3.82e-05	0.0006	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.8e-05	0.000597	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	3.76e-05	0.000591	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	3.76e-05	0.000591	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	3.72e-05	0.000585	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.71e-05	0.000583	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL2—acquired immunodeficiency syndrome	3.65e-05	0.000574	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.64e-05	0.000572	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	3.64e-05	0.000572	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.64e-05	0.000572	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	3.61e-05	0.000567	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.6e-05	0.000566	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.6e-05	0.000566	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.6e-05	0.000566	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	3.6e-05	0.000565	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD40LG—acquired immunodeficiency syndrome	3.59e-05	0.000564	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.57e-05	0.000561	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.55e-05	0.000558	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.55e-05	0.000558	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD8A—acquired immunodeficiency syndrome	3.55e-05	0.000558	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CSF2—acquired immunodeficiency syndrome	3.55e-05	0.000558	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	3.54e-05	0.000556	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.5e-05	0.00055	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	3.49e-05	0.000549	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	3.49e-05	0.000548	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	3.47e-05	0.000545	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	3.46e-05	0.000544	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	3.45e-05	0.000542	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	3.43e-05	0.000539	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.42e-05	0.000538	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.42e-05	0.000538	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-B—acquired immunodeficiency syndrome	3.41e-05	0.000536	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.38e-05	0.000532	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.38e-05	0.000532	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	3.33e-05	0.000523	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.32e-05	0.000521	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	3.26e-05	0.000513	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.26e-05	0.000512	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.26e-05	0.000512	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.25e-05	0.000511	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	3.21e-05	0.000505	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.21e-05	0.000504	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MBL2—acquired immunodeficiency syndrome	3.19e-05	0.000502	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	3.18e-05	0.0005	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	3.13e-05	0.000492	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.06e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.06e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.06e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.06e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—IL6—acquired immunodeficiency syndrome	3e-05	0.000472	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	2.94e-05	0.000462	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	2.94e-05	0.000462	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.93e-05	0.000461	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	2.91e-05	0.000458	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	2.91e-05	0.000457	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	2.91e-05	0.000456	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.9e-05	0.000455	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.9e-05	0.000455	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	2.85e-05	0.000449	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.83e-05	0.000445	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	2.82e-05	0.000443	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	2.8e-05	0.00044	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.77e-05	0.000436	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.77e-05	0.000435	CbGpPWpGaD
Acetylsalicylic acid—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.75e-05	0.000432	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	2.71e-05	0.000426	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	2.71e-05	0.000426	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	2.7e-05	0.000425	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	2.69e-05	0.000423	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.65e-05	0.000417	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.65e-05	0.000416	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CD4—acquired immunodeficiency syndrome	2.63e-05	0.000413	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.62e-05	0.000412	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.61e-05	0.000409	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.58e-05	0.000405	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.57e-05	0.000403	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.54e-05	0.000399	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CCR2—acquired immunodeficiency syndrome	2.5e-05	0.000394	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—ALB—acquired immunodeficiency syndrome	2.5e-05	0.000393	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000381	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	2.42e-05	0.00038	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.36e-05	0.000371	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IFNG—acquired immunodeficiency syndrome	2.36e-05	0.000371	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.35e-05	0.000369	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.33e-05	0.000366	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.33e-05	0.000366	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.32e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	2.3e-05	0.000362	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.29e-05	0.00036	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.29e-05	0.00036	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	2.29e-05	0.00036	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD4—acquired immunodeficiency syndrome	2.28e-05	0.000358	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	2.27e-05	0.000357	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.26e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNA1—acquired immunodeficiency syndrome	2.25e-05	0.000354	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.24e-05	0.000352	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.21e-05	0.000347	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD79A—acquired immunodeficiency syndrome	2.19e-05	0.000344	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	2.19e-05	0.000344	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL6—acquired immunodeficiency syndrome	2.15e-05	0.000337	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.14e-05	0.000337	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.12e-05	0.000333	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IFNG—acquired immunodeficiency syndrome	2.11e-05	0.000332	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.1e-05	0.00033	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.1e-05	0.00033	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL2—acquired immunodeficiency syndrome	2.1e-05	0.00033	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	2.06e-05	0.000323	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.05e-05	0.000322	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.05e-05	0.000322	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD4—acquired immunodeficiency syndrome	2.04e-05	0.00032	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.01e-05	0.000315	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.93e-05	0.000303	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.89e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.88e-05	0.000295	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL2—acquired immunodeficiency syndrome	1.87e-05	0.000295	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.84e-05	0.00029	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.82e-05	0.000287	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.79e-05	0.000281	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD40LG—acquired immunodeficiency syndrome	1.78e-05	0.00028	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.78e-05	0.000279	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD8A—acquired immunodeficiency syndrome	1.76e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CSF2—acquired immunodeficiency syndrome	1.76e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.74e-05	0.000273	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-B—acquired immunodeficiency syndrome	1.7e-05	0.000267	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.69e-05	0.000266	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	1.68e-05	0.000264	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.67e-05	0.000263	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.65e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.64e-05	0.000258	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.62e-05	0.000254	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.52e-05	0.000239	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.52e-05	0.000239	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000223	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	1.42e-05	0.000223	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.36e-05	0.000213	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.31e-05	0.000205	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000205	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—acquired immunodeficiency syndrome	1.23e-05	0.000194	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.21e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.21e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.21e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.21e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.16e-05	0.000182	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.14e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—acquired immunodeficiency syndrome	1.1e-05	0.000173	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.06e-05	0.000167	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNG—acquired immunodeficiency syndrome	1.05e-05	0.000165	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.04e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—acquired immunodeficiency syndrome	1.01e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.96e-06	0.000156	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	9.73e-06	0.000153	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.47e-06	0.000149	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.41e-06	0.000148	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	9.4e-06	0.000148	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—acquired immunodeficiency syndrome	9.32e-06	0.000147	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.79e-06	0.000138	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.64e-06	0.000136	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.97e-06	0.000125	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.88e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	7.32e-06	0.000115	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.13e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.13e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	6.11e-06	9.6e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.03e-06	9.47e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	5.81e-06	9.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—acquired immunodeficiency syndrome	5.48e-06	8.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	4.73e-06	7.43e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.22e-06	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.12e-06	6.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.85e-06	6.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.54e-06	5.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	3.31e-06	5.19e-05	CbGpPWpGaD
